NGM Biopharmaceuticals Secures $13,485,015 Series C Funding Round

  • Feed Type
  • Date
    5/3/2013
  • Company Name
    NGM Biopharmaceuticals
  • Mailing Address
    630 Gateway Blvd South San Francisco, CA 94080
  • Company Description
    NGM is a privately-held drug discovery company committed to the identification and development of transformational biologics for diabetes, obesity, muscle wasting and other cardiometabolic diseases.
  • Website
    http://www.ngmbio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $13,485,015
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.